The Cirrus-HCM trial is an open-label, four-week study evaluating the efficacy of two dosages (50 mg and 100 mg) of EDG-7500 in patients diagnosed with either obstructive or nonobstructive HCM. The ...

Right-sided heart failure develops when the right side of the heart is too weak to pump blood to the lungs. This causes blood to back up into the venous system, limiting how much blood the heart can ...

Discover growth opportunities with Edgewise Therapeutics, Inc. in the hypertrophic cardiomyopathy market. Click for my EWTX ...

Shares of Edgewise Therapeutics and Cytokinetics diverged Wednesday after safety questions highlighted a heart disease study from Edgewise.

Across the study, two patients experienced “serious adverse events of atrial fibrillation (AF) requiring cardioversion,” Edgewise said. The rates of AF—a term for irregular heart rhythm—were in the ...

Dark leafy greens, fish, whole grains, low fat dairy products, and some carb sources may help manage diabetes and lower your risk of heart disease. Diabetes is a health condition in which the ...

Our vision is to innovate and incorporate promising technologies to communicate freely available, high-priority, high-quality content, which accelerates scientific progress and advances heart and ...

The staging system for heart attacks describes the extent of tissue damage to the heart. Stage 1 heart attacks do not cause any death of the heart tissue, while stage 4 causes severe damage.

For exclusive news and updates, subscribe to our When Calls the Heart Newsletter: When Calls the Heart Season 12 has come to a close, but Hearties can breathe a sigh of relief. The beloved series ...

Diastolic heart failure causes a stiff left ventricle that prevents the heart from relaxing between beats. Common symptoms include coughing, tiredness, and shortness of breath. Systolic and ...